Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group – Real-world observations
One therapy modality cannot replace another one. Although urgently required, quality of therapy has not improved in 2021.
Authors
- Jalid Sehouli (ORCID: https://orcid.org/0000-0002-5963-6623)
- Frederik Marmé (ORCID: https://orcid.org/0000-0002-6591-3367)
- Gabriele Elser
- Nikolaus de Gregorio (ORCID: https://orcid.org/0000-0002-0037-127X)
- Florian Heitz (ORCID: https://orcid.org/0000-0002-2412-0352)
- Felix Hilpert (ORCID: https://orcid.org/0000-0002-3492-9577)
- Lars Hanker (ORCID: https://orcid.org/0000-0001-6697-018X)
- Jacobus Pfisterer (ORCID: https://orcid.org/0000-0001-9938-4689)
- Andreas du Bois (ORCID: https://orcid.org/0000-0002-8477-506X)
- Pauline Wimberger (ORCID: https://orcid.org/0000-0002-7380-577X)
- Laura Holtmann (ORCID: https://orcid.org/0009-0009-5776-5614)
- Linn Wölber
- Markus Kerkmann (ORCID: https://orcid.org/0000-0002-7151-5875)
- Philipp Harter (ORCID: https://orcid.org/0000-0002-9663-5005)
- Sven� Mahner (ORCID: https://orcid.org/0000-0002-2224-5709)
Institutions
- Gynecologic Oncology Group (US)
- Heidelberg University (DE)
- Eppendorf (Germany) (DE)
- University Hospital Heidelberg (DE)
- Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe (DE)
- University Hospital Schleswig-Holstein (DE)
- Kliniken Essen-Mitte (DE)
- SLK-Kliniken Heilbronn (DE)
- University Hospital Carl Gustav Carus (DE)
- Clinical Research Center Kiel (DE)
- Charité - Universitätsmedizin Berlin (DE)
- Ludwig-Maximilians-Universität München (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-02-15
- DOI
- https://doi.org/10.1016/j.ejso.2025.109696
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- AstraZeneca
- GlaxoSmithKline